Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Back to the letter...

I'm not sure that I understand your question, borredo. Are you asking if "a group of shareholders" with a combined total of 13% of the total number of outstanding shares would have any leverage to influence the board of directors of a company? I guess it would depend on the quality of the company, wouldn't it seem that way to you?

Do you think Warren Buffet would be concerned if 13% of the shareholders of Berkshire Hathaway grouped together to send in a letter to the board of directors? Would Warren take that seriously? I think the quality of both the man and his company would dictate that he would, however, it is probably also true that 13% of his shareholders have only ever grouped together to plan outtings and events for their next shareholder meeting.

I'd like to think that PTSC shares that same quality.

Share
New Message
Please login to post a reply